{"id":"W4402561053","doi":"10.1016/j.annonc.2024.08.1060","title":"1001MO Initial safety, pharmacokinetics, and anti-tumor activity data of TCER IMA401, a MAGEA4/8-directed half-life extended TCR bispecific, in phase I dose escalation","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Cilag; Ipsen; Oncolytics Biotech; Swedish Orphan Biovitrum; Regeneron Pharmaceuticals; F. Hoffmann-La Roche; Daiichi Sankyo Europe; Sanofi; Servier; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Pharmacokinetics; T-cell receptor; Pharmacology; Oncology; Immunology; T cell","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007079408,0.0005736453,0.0007107764,0.0003856235,0.0003535566,0.0005727303,0.0003911757,0.0005677403,0.002727316],"category_scores_gemma":[0.0008064355,0.0003261241,0.0004615245,0.0002613271,0.0004336424,0.0004995762,0.0001652978,0.002489605,0.0006581414],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007429052,"about_ca_system_score_gemma":0.0006865633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001409246,"about_ca_topic_score_gemma":0.002326995,"domain_scores_codex":[0.9997295,0.00009071526,0.0000110019,0.00004486741,0.00004708994,0.00007685494],"domain_scores_gemma":[0.9996018,0.0001155194,0.00006274358,0.00005713304,0.00003782712,0.000124983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1348405,0.0264406,0.01128252,0.000343089,0.000588541,0.0007070565,0.0005310872,0.009828513,0.5623345,0.0008898509,0.01103722,0.2411764],"study_design_scores_gemma":[0.02899824,0.498183,0.06771521,0.00009864726,0.001147784,0.002263289,0.0002149913,0.01420973,0.3494434,0.001098534,0.0365136,0.0001136146],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917325,0.001409037,0.001523863,0.0004501194,0.0000737094,0.0002331368,0.001138731,0.0001972978,0.003241526],"genre_scores_gemma":[0.990474,0.0006429834,0.001302509,0.0003136019,0.00004355266,0.0002220005,0.002201874,0.00008293099,0.004716453],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002727316,"threshold_uncertainty_score":0.009123802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2060912645721676,"score_gpt":0.5038702914157137,"score_spread":0.2977790268435461,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}